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Abstract: Viruses have great potential as nanotools in medicine for gene transfer, targeted 
gene delivery, and oncolytic cancer virotherapy. Here we have studied cell death mechanisms of 
canine parvovirus (CPV) to increase the knowledge on the CPV life cycle in order to facilitate 
the development of better parvovirus vectors. Morphological studies of CPV-infected Norden 
laboratory feline kidney (NLFK) cells and canine fibroma cells (A72) displayed characteristic 
apoptotic events. Apoptosis was further confirmed by activation of caspases and cellular DNA 
damage. However, results from annexin V-propidium iodide (PI) labeling and membrane 
polarization assays indicated disruption of the plasma membrane uncommon to apoptosis. 
These results provide evidence that secondary necrosis followed apoptosis. In addition, two 
human cancer cell lines were found to be infected by CPV . This necrotic event over apoptotic 
cell death and infection in human cells provide insightful information when developing CPV 
as a nanotool for cancer treatments.
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Introduction
Autonomous parvoviruses are small nonenveloped viruses that have oncolytic 
  capabilities and have been exploited as a nanotool in medicine. Parvoviruses have been 
used as an antitumor agent, immune cell activator, and as a targeted gene vector.1–5 
In addition, CPV virus-like particles have been employed in delivery of drugs.6 On 
the other hand, parvovirus H-1 has also been utilized in oncolytic virotherapy.7,8 
Oncolytic virotherapy means the use of lytic viruses to kill tumor cells while normal 
cells are not infected by the virus. This kind of new cancer therapy is needed to treat 
cancers that are resistant to conventional cancer treatments.9 Lysis of cancer cells 
releases tumor-associated antigens that induce anticancer immunity and this type of 
treatment can also be seen as a cancer vaccine. Advantage of this effect is immune 
memory to prevent relapse and metastasis.10 In order to use virotherapy it is important 
to understand how these virus nanotools behave intracellularly.
There are three major morphologically and biochemically distinct types of cell 
death: apoptosis (type 1 cell death), autophagy (type 2 cell death), and necrosis (type 3 
cell death).11 Apoptosis is characterized by nuclear and cytoplasmic condensation, 
maintenance of membrane integrity, and formation of apoptotic bodies; whereas, 
necrotic cells swell, lose plasma membrane integrity rapidly, and eventually lyse. 
Autophagic cell death is characterized by formation of vacuoles surrounded by a double 
membrane and by a lack of chromatin condensation.11–14 In vivo apoptotic bodies are 
rapidly phagocytized. However, when studied in vitro late apoptotic cells may lose International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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membrane integrity and become necrotic.14 This terminal 
phase of in vitro cell death, called secondary necrosis, 
occurs in apoptotic cells in the absence of phagocytic cells. 
Because secondary necrosis is an end stage of apoptosis it 
can be discriminated from primary necrosis by occurrence 
of apoptotic and necrotic cell death parameters.15,16 Many 
viruses are known to cause these types of cell death, for 
example HIV (apoptosis),17 hepatitis C virus (autophagy),18 
bovine parvovirus (necrosis),19 and porcine reproductive and 
respiratory syndrome virus   (secondary necrosis).20
A parvovirus infection has multiple effects on host cells 
depending on the infecting virus and the type of cell used. 
Infection arrests cell cycle21–24 and induces cell death through 
different cell death mechanisms. Aleutian mink disease 
virus,25 feline panleukopenia virus (FPLV),26 human parvo-
virus B19,27–29 parvovirus H-1,30 and rat parvovirus31 have 
been reported to induce apoptotic cell death while bovine 
parvovirus infected cells are necrotic.19 On the other hand 
apoptosis induced in H-1 infection progresses to a necrotic 
cell death state in specific cell types.32 However, H-1 infected 
apoptosis-resistant glioma cells die by nonapoptotic mecha-
nism by gathering of lysosomal cathepsins in cytoplasm.33 
Also a minute virus of mice (MVM) infection induces cell 
death different from conventional apoptotic/necrotic cell 
death pathways by interfering with the cytoskeleton and 
changing the substrate specificity of casein kinase II.34 Due 
to the fact that CPV is being investigated as a novel nano-
material for gene delivery and tumor targeting, it is of great 
interest to have a clearer understanding of how this virus 
causes cell death.
CPV and FPLV are classified as host range variants of 
feline parvovirus (FPV).35,36 The linear single-stranded DNA 
genome of CPV codes for two structural proteins, VP1 and 
VP2, and two nonstructural proteins NS1 and NS2.37 CPV 
causes mostly enteritis and myocarditis in puppies, but also 
leukopenia may be observed in dogs with a CPV infection.38 
CPV uses transferrin receptor (TfR) to enter canine or feline 
cells and has been shown to bind to human TfR, but there is no 
evidence of CPV infecting humans.39 Interestingly, apoptotic 
cells have been observed in studies concerning in vivo tissue 
samples from CPV- and FPLV-infected animals.40 In cultured 
canine and feline lymphocytes, a CPV or FPLV infection, 
respectively, displayed characteristics of cell death caused 
by apoptosis.26 Here we have examined the mechanism of 
cell death to assist the development of CPV vectors for use 
in virotherapy. Although CPV has a limited host range, it has 
previously been shown to be able to infect a human cancer 
cell line.39 This work was extended here.
Material and methods
Cells and virus
Two permissive cell lines widely used in CPV studies were 
used. NLFK cells and a canine fibroma cell line A72 (gifts 
from Colin Parrish, Cornell University, Ithaca, NY) were 
grown in Dulbecco’s modified Eagle’s medium. Human cell 
HepG2, a hepatocellular carcinoma cell line, was cultured in 
Hepatocyte Wash Media (Invitrogen, Carlsbad, CA) with 1% 
L-glutamine (Invitrogen), and HeLa, a cervical adenocarci-
noma cell line, was maintained in Eagle’s minimum essential 
medium. All cell line media were supplemented with 10% 
fetal calf serum (PAA Laboratories, Pasching, Austria), 1% 
PenStrep (Invitrogen), and incubated at 37°C in 5% CO2. 
CPV type 2, derived from an infectious clone as previously 
described,41 was propagated in NLFK cells in 500 cm2 cell 
culture flasks (Nunc, Roskilde, Denmark) for seven days 
and then stored at -20°C. Cell debris was removed from 
300 mL of virus culture medium by centrifugation and the 
supernatants were concentrated by ultrafiltration (30 kDa 
filter; Millipore Corporation, Bedford, MA). The virus was 
pelleted by ultracentrifugation at 173,000 × g for one hour 
and resuspended in 1 mL of phosphate-buffered saline (PBS) 
pH 7.4. The suspension was sonicated with low power and 
extracted with chloroform. The CPV-containing aqueous 
layer was used to infect permissive cells at multiplicity of 
infection (MOI) 50 and human cancer cell lines at MOI 0.1, 
determined by titration methods.
Differential interference contrast 
microscopy
To show morphological changes of cells in a CPV infection, 
differential interference contrast (DIC) microscopy was used. 
NLFK and A72 cells grown to 80% confluency on coverslips 
(diameter, 13 mm) were inoculated with CPV for 15 minutes 
at 37°C and incubated for 12 to 72 hours. Unfixed slips were 
mounted and immediately examined with a laser scanning 
fluorescence microscope (LSM 510; Zeiss Axiovert 100 M; 
Carl Zeiss MicroImaging, Inc., New York, NY).
Flow cytometry for DNA content
To study cell cycle of CPV-infected cells flow cytometry 
was used.42 CPV- or mock-infected NLFK and A72 cells 
were harvested by trypsinization, washed with PBS, and 
fixed with ice cold 70% ethanol. Fixed cells were incubated 
with 0.15 mg/mL Ribonuclease A (Roche, Mannheim, 
Germany) for 30 minutes at 37°C and labeled with 50 µg/mL 
propidium iodide (Molecular Probes, Inc., Eugene, OR.) 
for 15 minutes. Samples were analyzed with FACSCalibur International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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(Becton   Dickinson, Franklin Lakes, NJ) with a 488 nm laser 
line and analyzed using Cell Quest (Becton   Dickinson) and 
FlowJo (Tree Star, Inc., Ashland, OR) software. A total of 104 
cells were analyzed in each assay to create a cytogram. These 
experiments were repeated four times with similar observa-
tions and one experiment was utilized for representation.
Flow cytometric analyses  
for differentiating the type of cell death
The type of cell death was analyzed with annexin V and PI 
double staining.43 NLFK and A72 cells grown in 8.8 cm2 
dishes (Nunc) were CPV- or mock-infected and incubated 
for the indicated time points of 12 to 72 hours. To double-
label the cells, 105 trypsinized cells were washed with 
annexin V binding buffer (10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 140 mM NaCl 
and 2.5 mM CaCl2, pH 7.4). Resuspended cells in 100 µL 
of binding buffer were stained by adding 5 µL of annexin V 
Alexa Fluor 488 (Molecular Probes, Inc.) and with 3 µM 
PI. As a positive control, cells were treated with 0.5 µM 
staurosporine (STS; Sigma, St. Louis, MO) for 16 hours 
to induce apoptosis. After 15 minutes incubation at room 
temperature, fluoresence was measured by flow cytometry 
using a FACSCalibur with a 488 nm laser line and Cell 
Quest software (Becton Dickinson). A total of 104 cells were 
analyzed in each assay to create a cytogram. Results were 
analyzed with FlowJo software (Tree Star). Experiments 
were repeated five times with similar observations, and 
results of one experiment are shown.
Caspase assays
In order to indicate the mechanism of apoptosis occuring 
in CPV-infected cells caspase activation was assayed. 
  Caspase-Glo 8, 9, and 3/7 assay systems (Promega, Madison, 
WI) were used according to manufacturer’s instructions. 
Cells were grown and infected at MOI 50 on 96-well plate 
(Greiner Bio-One, Maybachstrasse, Germany). At the indi-
cated time points (6 to 72 hours post-infection), caspase 
reagent was added to wells and incubated at room tempera-
ture for one hour in the dark. Luminescence was measured 
with Wallac Victor2 1420 Multilabel counter (PerkinElmer, 
Waltham, MA). STS- (1 µM, 12 hours; sigma) treated cells 
were used as a positive control and caspase inhibitors were 
used to inhibit caspase activation. Caspase inhibitor Z-VAD-
FMK   (Promega) was used to inhibit caspase 3/7. Inhibitors 
for caspase 8 (Z-IETD-FMK) and 9 (Z-LEHD-FMK) were 
from Caspase-family   inhibitor set IV (BioVision, Inc,) 
Mountain View, CA. Experiments were repeated three times. 
  Statistical analysis was performed with   Kruskall–Wallis 
  analysis (KaleidaGraph software, Synergy Software, 
  Reading, PA). Significance level was set to 0.05.
Immunofluorescence microscopy
To study molecular and biochemical changes in infected 
cells, NS1 and H2A.X proteins were observed by immuno-
fluorescence microscopy. CPV- and mock-infected NLFK 
cells grown on coverslips were fixed with ice cold methanol 
and double-labeled with biotinylated monoclonal mouse 
anti-phospho-histone H2A.X antibody (clone JBW301, 
Upstate Biotechnology, Inc., Lake Placid, NY) and with a 
monoclonal mouse antibody to the nonstructural protein 
1 (NS1) of CPV (gift from Colin Parrish). Biotinylated 
H2A.X antibody was detected with a streptavidin Alexa 
Fluor 488 conjugate (Molecular Probes, Inc.) while the NS1 
antibody was conjugated to Cy5 (Molecular Probes, Inc.) 
according to manufacturer’s instructions. The samples were 
examined with a laser scanning fluorescence microscope 
(LSM 510; Zeiss Axiovert 100 M, Carl Zeiss, Inc.) by using 
the excitation and emission settings appropriate for the dye 
used. Infectivity was determined by calculating the ratio 
of cells with fluorescent nuclei to the total number of cells 
(n = 1,000). KaleidaGraph software (Synergy Software) was 
used to calculate results and draw graphs.
Electron microscopy
Nuclear fragmentation was assessed using electron 
microscopy. NLFK cells grown on 8.8 cm2 dishes (Nunc) 
were inoculated with CPV for 15 minutes at 37°C and 
incubated for 24 to 72 hours. After appropriate times per 
infection, cells were rinsed three times with 0.1 M PBS pH 
7.4 and fixed with 2.5% glutaraldehyde in 0.1 M PBS for 
one hour. Cells were washed with 0.1 M PBS pH 7.4 and 
postfixed in 1% osmium tetroxide in 0.1 M PBS pH 7.4 for 
one hour at 4°C. Samples were dehydrated in ethanol, stained 
with uranyl acetate, and embedded in Epon LX-112 (Ladd 
Research Industries, Williston, VT). Thin sections were cut 
and samples were viewed at 60 kV with a JEOL JEM-1200EX 
transmission EM (Jeol Ltd., Tokyo, Japan).
DNA fragmentation
DNA fragmentation was assessed as previously described.44 
Floating and adherent cells were collected and embedded 
in 1.5% low melting point agar (Boehringer   Mannheim, 
  Mannheim, Germany) and treated with lysis buffer 
(50 mM NaCl, 20 mM Tris-HCl, pH 8.0, 20 mM EDTA, 
0.5% sodium   sarcosyl, 50 µg/mL Ribonuclease A (Roche), International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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100 µg/mL   proteinase K [Roche] for one hour at 37°C. Cells 
were washed with buffer tris/borate/ethylenediaminetet-
raacetic acid (EDTA) (TBE) buffer and resolved in 1% 
agarose gel.
Flow cytometric analyses  
of membrane integrity
To analyze if a CPV infection has an effect on plasma and mito-
chondria membrane potentials, 3,3´-dihexyloxacarbocyanine 
iodide (DiOC6(3); Molecular Probes, Inc.) and DePsipher 
(R&D Systems, Inc., Minneapolis, MN) were used.45 NLFK 
cells grown in 8.8 cm2 dishes (Nunc) were CPV- or mock-
infected, and incubated for 12 to 24 hours. DiOC6(3) was 
added to trypsinized cells at a final concentration of 20 nM 
and incubated for 15 minutes at 37°C. As a positive control 
for each sample, cells were also labeled in the presence of 
100 µM protonophore carbonyl cyanide m-chlorophenyl-
hydrazone (CCCP; Sigma). For analysis of mitochondria 
membrane integrity, DePsipher was added to trypsinized 
cells at a final concentration of 10 µg/mL and incubated for 
30 minutes at 37°C. As a positive control, cells were also 
labeled in the presence of 100 nM K+-selective ionophore 
valinomycin (Sigma). Stained cells were analyzed with 
flow cytometry using a FACSCalibur with a 488 nm laser 
line and Cell Quest software (Becton Dickinson). A total 
of 104 cells were analyzed in each assay to create the cyto-
grams. Results were analyzed with FlowJo software (Tree 
Star). These experiments were repeated four times with 
similar observations, and one experiment was utilized for 
representation.
Flow cytometry studies for expression  
of NS1 protein in human cells
HepG2 and HeLa cells were collected by trypsinization 
with 0.5% Trypsin/EDTA (Invitrogen) in PBS (Invitrogen) 
at 24 hours post-infection, washed once with fresh media 
(500 µL) and then washed again with PBS. For NS1 expres-
sion analysis, 5  × 105 of CPV- or mock-infected cells at 
MOI 0.1 were resuspended in 500 µL of ice-cold PBS and 
fixed with ice-cold methanol. Immunolabelling proceeded 
with a monoclonal mouse antibody to the nonstructural 
protein 1 (NS1) of CPV (gift from Colin Parrish) and 
detected with a goat anti-mouse Alexa Fluor 488 conjugate 
(Molecular Probes, Inc.). All samples were analyzed on 
the FACSCalibur flow cytometer (Becton Dickinson), data 
collected using Cell-Quest software (Becton Dickinson), 
and statistical analysis completed by FlowJo software 
(Tree Star).
Results
General course of oncolytic behavior
Both cell lines, NLFK and A72, have been used in several 
studies concerning canine parvovirus infection.46–50 DIC 
microscopy of these cell lines revealed that CPV infection 
induced cytopathic effects faster in NLFK cells than in 
A72 cells (Figure 1). Only a minority of the CPV-infected 
NLFK cells were rounded at 24 hours post infection, but at 
48 hours post infection most of the cells had morphological 
changes, cell shrinkage, condensed cytoplasm, and immense 
cell detachment occurring (Figure 1a). In A72-infected cells, 
roundness as well as detachment was observed at 48 hours 
post infection and the cell changes were more evident at 
72 hours post infection (Figure 1b). Immunofluorescence 
studies showed that CPV antigens (NS1 protein) were 
found in the nucleus in 30% of NLFK cells at 12 hours 
post-infection, and at 24 hours post-infection almost all the 
cells were infected (Figure 5a). In A72 cells only a minor-
ity of the cells were infected at 24 hours post-infection, 
but at 48 hours post-infection 58% stained positive for 
NS1 (data not shown). Since time points of 12 to 24 hours 
post-infection in NLFK-infected cells indicated severe 
mock
CPV
A 12 h p.i. 24 h p.i. 48 h p.i.
B 24 h p.i. 48 h p.i. 72 h p.i.
mock
CPV
Figure 1 Morphological changes of CPV-infected cells. Differential interference 
contrast microscopy pictures of mock- and CPV-infected cells. (a) NLFK cells at 
12 hours, 24 hours, and 48 hours post infection. (b) A72 cells at 24 hours, 48 hours, 
and 72 hours post infection. Arrowheads point to rounded cells. Bars 10 µm.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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  morphological changes and time points of 24 to 72 hours 
post-infection in A72-infected cells showed similar changes, 
these time points were used respectively for experiments to 
study cell death mechanisms.
CPV induces cell cycle arrest
Analysis of the DNA content of CPV-infected NLFK and 
A72 cells showed that cells accumulated progressively at 
the S phase (Figure 2). This S arrest was found to be time 
dependent for both cell lines. The mock-infected NLFK 
cells showed 19.3% of the cells in S phase whereas CPV-
infected cells showed 30.4% after 12 hours, which further 
increased to 50.2% after 24 hours. The mock-infected A72 
cells showed 6.4% of the cells in S phase, whereas CPV-
infected cells showed 10.3% after 24 hours which further 
increased to 16.7% after 72 hours. The mock-infected NLFK 
cells showed 64.2% of the cells in G0/G1 phase whereas CPV-
infected cells showed 55.9% after 12 hours, which further 
decreased to 18.5% after 24 hours. The mock-infected A72 
cells showed 72.9% of the cells in G0/G1 phase, whereas 
CPV-infected cells showed 62.6% after 24 hours which 
further decreased to 25.6% after 72 hours, probably due 
to delayed effects of viral infection in this cell line. These 
results indicated that CPV infection arrests cell cycle at the 
S phase and CPV-infected cells accumulated unusually high 
amounts of DNA.
Differentiating the type of cell death  
in CPV infected cells
Annexin V is often used to study the translocation of 
phosphatidylserine from the inner leaflet of the plasma 
membrane to the outer leaflet in apoptotic cells.51 Thus 
double-labeling with annexin V with PI could be used to 
differentiate between different types of cell death. The 
cytogram of cells undergoing apoptosis (Figure 3, STS) 
as compared to mock-infected cells (Figure 3a, mock) 
in this double-labeling experiment should show early 
  apoptotic cells in the lower right quadrant staining positive 
for annexin V and PI negative. Late apoptotic or necrotic 
cells are in the upper right quadrant positive for both PI and 
annexin V staining. Living cells in the lower left quadrant 
are negative for both fluorescent probes. Figure 3a shows 
the results from such a double-labeling experiment with 
CPV-infected NLFK cells. A small increase of 8% in the 
proportion of double positive cells (late apoptotic/necrotic 
cells) could be seen already from 12 to 17 hours post infec-
tion. At 23 hours post infection, 50.6% of the cells were 
late apoptotic or necrotic. When viewing the early apoptotic 
cells (lower right quadrant/annexin V positive) (Figure 3a), 
an increase from 2.43% to 22.9% for time points of 12 to 
23 hours post infection was observed. As the course of 
infection progresses, an increase in early apoptotic cells 
accompanied by an increase of late apoptotic/necrotic cells 
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were similar to the findings seen in A72-infected cells 
(Figure 3b). From 24 to 48 hours post-infection, and then 
to 72 hours post-infection, there was a consistent increase 
from 8.55%, to 18.4%, and to 22.3%, respectively, in the 
accumulation of late apoptotic or necrotic A72 cells. Early 
apoptotic cells did increase from 7.56% to 20% at 24 to 
48 hours post-infection, but declined to 10.4% at 72 hours 
post infection. In both NLFK (data not shown) and A72 
(Figure 3b) cell types, when the progress of the infection 
is pushed to later time points as in 72 hours post-infection, 
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more cells were seen as late apoptotic or necrotic cells with 
a decrease in early apoptotic cells. These results indicated 
that apoptosis is initiated in CPV-infected cells, but later 
during the infection, the plasma membrane is damaged 
while the cells become necrotic.
Caspase activation in CPV  
infected cells
To investigate the apoptotic mechanism in CPV-infected 
cells, caspase activity assays were utilized. In CPV-infected 
NLFK cells caspase 9 was activated at 6 through 48 hours post 
infection and caspases 8 and 3/7 were activated at 12 through 
48 hours post infection (Figure 4a). In CPV-infected A72 cells, 
caspases 9 and 3/7 were activated at 12 through 72 hours post 
infection, while caspase 8 activation was detected at 24 hours 
post infection (Figure 4b). In STS-treated NLFK and A72 
cells, all these caspases were activated. When inhibitors were 
used the activation of caspases was lower (data not shown). 
Activation of caspases indicates apoptotic cell death.
DNA damage in CPV-infected NLFK cells
The accumulation of high levels of H2A.X phosphorylation 
coincide with severe DNA damage and is a very early and 
accurate indicator of apoptosis.52,53 Thus H2A.X immunola-
belings were made to further study the apoptotic mechanism 
in NLFK cells. The percentage of phospho-H2A.X and NS1 
positive cells were calculated (Figure 5a). Results showed 
that phosphorylation of histone increased with NS1 posi-
tive cells. At 24 hours post infection 76% of the cells had 
phosphorylated H2A.X, indicating induction of apoptosis in 
CPV-infected cells. Condensation of the nucleus and DNA 
were also detected with electron microscopy (Figure 5b). 
Condensed cytosol, nuclear envelope changes, fragmented 
nuclear components, as well as fragmented DNA could be 
detected at 24 hours post infection and at 48 hours post infec-
tion (Figure 5b). DNA was also fragmented as shown from 
electrophoresis of total cellular DNA after 24 hours post 
infection (Figure 5c lane 2). At 48 hours post infection the 
fragmentation of DNA was more severe (Figure 5c lane 3).
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Mitochondria are involved  
in CPV-induced cell death
Flow cytometric experiments that tested for the loss of 
  mitochondrial membrane potential were completed to study 
the consequence of apoptosis in CPV-infected cells. DiOC6(3) 
is known to respond to changes in both the mitochondrial and 
plasma membrane potential, but DePsipher measures only 
changes in the mitochondrial membrane potential.45 As shown 
in Figure 6a for NLFK-infected cells, membrane depolariza-
tion was detected at 17 hours post infection with a decrease 
in DiOC6(3) fluorescence and depolarization had increased at 
23 hours post-infection. DePsipher on the other hand aggre-
gates upon mitochondrial membrane polarization forming a 
red fluorescent compound. When the mitochondrial membrane 
potential is disturbed, the dye reverts to its green monomeric 
form. A decrease of 65% to 14% in red   fluorescence (FL2-H, 
upper left quadrant) was detected from 18 to 24 hours post 
infection, respectively. Green fluorescence (FL1-H, upper 
right quadrant) had increased from 28.3% to 73.8% from 18 
to 24 hours post infection, respectively (Figure 6b), indicating 
that mitochondrial depolarization had occurred. Some red fluo-
rescence was also seen in depolarized cells indicating polarized 
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Figure 5 Biochemical and molecular changes in CPV-infected NLFK cells. (a) Phosphorylation of histone H2A.X. CPV-infected cells were fixed at different time points 
post infection and labeled with anti-phospho-histone H2A.X and anti-NS1 antibodies (a marker of virus protein expression). Percentage of H2A.X and NS1 positive cells 
were calculated (n = 1,000). m = mock-infected cells 24 hours post infection. Error bars indicate standard deviations. (b) and (c) Condensation and fragmentation of the 
nucleus and DNA during infection. (b) Transmission electron microscopy pictures of mock-infected (48 hours post-infection) and CPV-infected nucleus at 24 hours post-
infection and 48 hours post-infection. Bars 1 µm. Arrows show nuclear membrane blebbing. (c) Agarose gel electrophoresis showing fragmentation of DNA in infected 
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mitochondria (Figure 6b 18 hours and 24 hours). Depolarization 
of mitochondria indicates involvement of mitochondria in cell 
death pathway that can be either apoptotic or necrotic.11
CPV infection of human tumor cell lines
To confirm the relevance of CPV in human systems, a hepa-
tocyte and cervical tumor cell lines were infected with CPV 
(Table 1). Since the expression of NS1 protein is an indicator 
of the synthesis and amplification of viral DNA replicative 
forms, monitoring of NS1 immunolabelled infected cells by 
flow cytometry was conducted. The NS1 expression analyzed 
by flow cytometry indicated that there is indeed infection of 
both cell lines, but at a much smaller amount compared to 
NLFK and A72 cells.
Discussion
As a first step towards the use of CPV in virotherapy, its 
pathogenetic mechanisms of cell death was investigated. The 
observed morphological changes and immense cell detach-
ment (Figure 1) provided initial evidence that cell death has 
occurred through apoptosis.11 When flow cytometry was used 
with annexin V and PI staining (Figure 3), characteristic early 
apoptotic and late apoptotic/necrotic cells were similar to 
those described for differentiating between the types of cell 
death.54 These findings indicated that the longer the infection 
occurs, more of the cells accumulated in the early apoptosis 
stage become late apoptotic or necrotic cells. This suggests 
that in a CPV infection, cells undergo early apoptosis and 
eventually accumulate as secondary necrotic cells.
In support of the view that apoptotic cell death was occur-
ring, caspase 8, 9, and 3/7 activation was seen (Figure 4) in 
both cell lines. Activation of caspases is a central mechanism 
in apoptotic cell death.55 Our results showed that caspase 9 
is activated early in a CPV infection and activation of cas-
pase 8 was detected later (Figure 4). Caspase 8 is included 
in death receptor mediated apoptosis while caspase 9 acti-
vation is involved in the intrinsic mitochondrial apoptotic 
pathway.55,56 Caspase 8 has been reported to be activated 
Table 1 CPV infection of human tumor cell lines 
Mock 1 Mock 2 wt CPV 1 wt CPV 2
HepG2 0.17 0.41 4.89 5.06
HeLa 0.54 0.39 9.92 11.4
Notes: Mock- (24 hours post-infection) and CPV-infected (24 hours post-infection) 
cells were immunolabeled with monoclonal anti-NS1, detected by anti-mouse Alexa 
488 antibodies and analyzed with flow cytometer. Flow cytometry scatter diagrams 
of HepG2 and HeLa cells were used to gate 10,000 cells and the FL1 channel used to 
obtain the level of NS1 expression. Numbers represent percentage of cells displaying 
NS1 expression.
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in B19-induced apoptosis in erythroid cells and that this 
type of cell death may be linked to the apoptotic pathway 
downstream of the TNF receptor.57 CPV enters cells by 
binding to the transferrin receptor followed by clathrin 
mediated endocytosis.46,47 However, in CPV-infected cells 
caspase 8 could be activated downstream of death recep-
tors as reported for the B19 virus. Activation of caspase 9 
suggests involvement of the mitochondria in cell death.55 
Also, caspase 3/7 activation was detected in both cell 
lines (Figure 4) indicating that the cell death occurred in a 
caspase-dependent manner.
NLFK cells were used to further study the cell death 
events in CPV-infected cells. Characteristic death events were 
apparent including nuclear envelope changes, fragmented 
nuclear components, as well as damaged DNA (Figure 5), 
along with plasma and mitochondrial membrane depolar-
ization (Figure 6). Dramatic changes in the status of these 
apoptotic markers could be detected in CPV-infected NLFK 
cells after the beginning of viral protein synthesis as detected 
by the NS1 expression (Figure 5a). It has been suggested that 
the cytotoxicity of a parvoviral infection is caused by the NS1 
protein.27,29,30 The parvoviral NS1 protein binds DNA and has 
nickase, helicase, and ATPase activities.58 Phosphorylation 
of histone H2A.X is connected to double-stranded DNA 
breaks in apoptosis,52,53,59 and has been shown to occur even in 
response to a few breaks.60 In CPV-infected cells this histone 
was phosphorylated and DNA fragmentation, a hallmark of 
apoptosis, was observed (Figure 5).
In secondary necrosis, plasma membranes of infected 
cells can be altered. To investigate the consequence of a CPV 
infection on membranes, membrane potential experiments 
were conducted (Figure 6). These experiments provided 
evidence on increased plasma membrane permeability 
(Figure 6). DiOC6(3) indicated that mitochondrial mem-
brane potential and possibly also the plasma membrane had 
changed. The disturbance in the mitochondrial potential 
seen with DePsipher could account for the induction of 
apoptosis.61 Depolarization of the mitochondrial and plasma 
membrane are known to occur during apoptosis; in fact, 
these two phenomena may be interconnected and coordi-
nated by mitochondrial membrane depolarization.62 Mito-
chondrial depolarization will compromise ATP-production 
and lead to profound changes in cellular metabolism. This 
has been shown to occur during apoptosis and secondary 
necrosis.63–65
Characteristics of secondary necrosis were observed in 
our study. Disruption of the cell membrane (Figures 3 and 6), 
and extensive nuclear membrane blebbing (Figure 5, arrows), 
provide evidence that secondary necrosis follows apoptosis. 
This observed cell death of apoptosis and secondary necrosis 
has been observed in other viruses.20,66,67 Apoptotic bodies 
were not detected in CPV-infected cells (data not shown), but 
it has been reported earlier that in vivo secondary necrosis 
appears before apoptotic bodies are formed.68 Secondary 
necrosis takes place in vivo, eg, in the absence of phagocytes 
or when elimination of apoptotic cells fails. A consequence 
of secondary necrosis is uncontrolled lysis of dying cells 
releasing cellular debris that causes inflammation.16 Induc-
tion of necrosis and inflammation is beneficial in oncolytic 
virotherapy of cancer cells to activate the immune system. 
Tumor-associated antigens are released from lysed cells and 
induce anticancer immunity thus having a prolonged effect 
of cancer treatment.10
The present results are relevant to nanoveterinary 
medicine, and the area of cancer therapies if one were to use 
virus-based systems as antineoplastic agents. Due to the fact 
that overexpression of receptors are characteristic of human 
tumor cells, ie, TfR, parvovirus-based nanotherapies are 
being developed.69 In addition, rodent parvovirus H-1 was 
found to exert cytopathic effects on a human hepatocellular 
carcinoma cell line.70 It was also reported that HeLa cells 
were susceptible to infection by both CPV and FPV .39 In 
these studies lower infection rates were seen mostly due to 
permissivity of the particular cell line used. Similarly we 
have shown here that not only can HeLa be infected with 
CPV , but HepG2 cells can be as well (Table 1). Altogether, 
parvoviruses are well-suited candidates for vectors in viro-
therapies and it is noteworthy to understand the cytopathic 
effects of CPV on cell lines.
Virus-induced effects are cell line dependent as seen 
in this study by delayed lysis of A72 cells and lower NS1 
expression in human cells. When planning to use viruses as 
nanotools the outcome of the infection has to be studied in 
each case and for each cell line. CPV has favorable charac-
teristics for exploitation especially in cancer therapy. Infec-
tion induces cell cycle arrest and DNA damage leading to 
cellular lysis. If viruses are used in gene therapy or targeted 
delivery, oncolytic properties have to be eliminated. Taking 
into account its lytic infection, the ability to bind human TfR, 
and its nonpathogenicity in humans, CPV has the potential 
for use in oncolytic virotherapy.
Acknowledgments/disclosures
We thank Pirjo Kauppinen and Raimo Pesonen for techni-
cal assistance. This study was supported by the Academy of 
Finland (Contract # 102161).International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
427
Cell death mechanisms in a CPV infection
References
  1.  Enderlin M, Kleinmann EV, Struyf S, et al. TNF-alpha and the 
IFN-gamma-inducible protein 10 (IP-10/CXCL-10) delivered by 
parvoviral vectors act in synergy to induce antitumor effects in mouse 
glioblastoma. Cancer Gene Ther. 2009;16(2):149–160.
  2.  Wetzel K, Struyf S, Van Damme J, et al. MCP-3 (CCL7) delivered by 
parvovirus MVMp reduces tumorigenicity of mouse melanoma cells 
through activation of T lymphocytes and NK cells. Int J Cancer. 2007; 
120(6):1364–1371.
  3.  Russell SJ, Brandenburger A, Flemming CL, Collins MK, Rommelaere J. 
Transformation-dependent expression of interleukin genes delivered by 
a recombinant parvovirus. J Virol. 1992;66(5):2821–2828.
  4.  Malerba M, Daeffler L, Rommelaere J, Iggo RD. Replicating parvovi-
ruses that target colon cancer cells. J Virol. 2003;77(12):6683–6691.
  5.  Ponnazhagan S, Weigel KA, Raikwar SP, Mukherjee P, Yoder MC, Srivastava 
A. Recombinant human parvovirus B19 vectors: erythroid cell-specific deliv-
ery and expression of transduced genes. J Virol. 1998; 72(6):5224–5230.
  6.  Singh P, Destito G, Schneemann A, Manchester M. Canine   parvovirus-like 
particles, a novel nanomaterial for tumor targeting. J Nanobiotechnology. 
2006;4:2.
  7.  Lacroix J, Leuchs B, Li J, et al. Parvovirus H1 selectively induces 
cytotoxic effects on human neuroblastoma cells. Int J Cancer. 2010; 
Jan 19. [Epub ahead of print].
  8.  Herrero Y, Calle M, Cornelis JJ, et al. Parvovirus H-1 infection of human 
glioma cells leads to complete viral replication and efficient cell killing. 
Int J Cancer. 2004;109(1):76–84.
  9.  Liu TC, Kirn D. Gene therapy progress and prospects cancer: oncolytic 
viruses. Gene Ther. 2008;15(12):877–884.
  10.  Li QX, Liu G, Wong-Staal F. Oncolytic virotherapy as a personalized 
cancer vaccine. Int J Cancer. 2008;123(3):493–499.
  11.  Galluzzi L, Maiuri MC, Vitale I, et al. Cell death modalities: clas-
sification and pathophysiological implications. Cell Death Differ. 
2007;14(7):1237–1243.
  12.  do Vale A, Costa-Ramos C, Silva DS, et al. Cytochemical and ultrastruc-
tural study of anoikis and secondary necrosis in enterocytes detached 
in vivo. Apoptosis. 2007;12(6):1069–1083.
  13.  Hebert MJ, Takano T, Holthofer H, Brady HR. Sequential morpho-
logic events during apoptosis of human neutrophils. Modulation by 
  lipoxygenase-derived eicosanoids. J Immunol. 1996;157(7):3105–3115.
  14.  Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell 
death. Am J Pathol. 1995;146(1):3–15.
  15.  Krysko DV , Vanden Berghe T, D’Herde K, Vandenabeele P. Apoptosis 
and necrosis: detection, discrimination and phagocytosis. Methods. 
2008;44(3):205–221.
  16.  Silva MT, do Vale A, dos Santos NM. Secondary necrosis in multicel-
lular animals: an outcome of apoptosis with pathogenic implications. 
Apoptosis. 2008;13(4):463–482.
  17.  Andersen JL, Le Rouzic E, Planelles V . HIV-1 vpr: mechanisms of G2 
arrest and apoptosis. Exp Mol Pathol. 2008;85(1):2–10.
  18.  Ait-Goughoulte M, Kanda T, Meyer K, Ryerse JS, Ray RB, Ray R. 
Hepatitis C virus genotype 1a growth and induction of autophagy.   
J Virol. 2008;82(5):2241–2249.
  19.  Abdel-Latif L, Murray BK, Renberg RL, et al. Cell death in bovine par-
vovirus-infected embryonic bovine tracheal cells is mediated by necrosis 
rather than apoptosis. J Gen Virol. 2006;87(Pt 9): 2539–2548.
  20.  Costers S, Lefebvre DJ, Delputte PL, Nauwynck HJ. Porcine reproductive 
and respiratory syndrome virus modulates apoptosis during replication 
in alveolar macrophages. Arch Virol. 2008;153(8):1453–1465.
  21.  Oleksiewicz MB, Alexandersen S. S-phase-dependent cell cycle dis-
turbances caused by aleutian mink disease parvovirus. J Virol. 1997; 
71(2):1386–1396.
  22.  Op De Beeck A, Sobczak-Thepot J, Sirma H, Bourgain F, Brechot C, Cail-
let-Fauquet P. NS1- and minute virus of mice-induced cell cycle arrest: 
involvement of p53 and p21(cip1). J Virol. 2001;75(22): 11071–11078.
  23.  Morita E, Nakashima A, Asao H, Sato H, Sugamura K. Human parvo-
virus B19 nonstructural protein (NS1) induces cell cycle arrest at G(1) 
phase. J Virol. 2003;77(5):2915–2921.
  24.  Morita E, Tada K, Chisaka H, et al. Human parvovirus B19 induces 
cell cycle arrest at G(2) phase with accumulation of mitotic cyclins.   
J Virol. 2001;75(16):7555–7563.
  25.  Best SM, Wolfinbarger JB, Bloom ME. Caspase activation is required 
for permissive replication of aleutian mink disease parvovirus in vitro. 
Virology. 2002;292(2):224–234.
  26.  Ikeda Y, Shinozuka J, Miyazawa T, et al. Apoptosis in feline   panleukopenia 
virus-infected lymphocytes. J Virol. 1998;72(8):6932–6936.
  27.  Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K. Human par-
vovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid 
lineage cells. J Virol. 1998;72(4):3018–3028.
  28.  Poole BD, Karetnyi YV , Naides SJ. Parvovirus B19-induced apoptosis 
of hepatocytes. J Virol. 2004;78(14):7775–7783.
  29.  Poole BD, Zhou J, Grote A, Schiffenbauer A, Naides SJ. Apoptosis of 
liver-derived cells induced by parvovirus B19 nonstructural protein. 
J Virol. 2006;80(8):4114–4121.
  30.  Rayet B, Lopez-Guerrero JA, Rommelaere J, Dinsart C. Induction 
of programmed cell death by parvovirus H-1 in U937 cells: connec-
tion with the tumor necrosis factor alpha signaling pathway. J Virol. 
1998;72(11):8893–8903.
  31.  Ueno Y, Harada T, Iseki H, Ohshima T, Sugiyama F, Yagami K. 
Propagation of rat parvovirus in thymic lymphoma cell line C58(NT)d 
and subsequent appearance of a resistant cell clone after lytic infection. 
J Virol. 2001;75(8):3965–3970.
  32.  Ran Z, Rayet B, Rommelaere J, Faisst S. Parvovirus H-1-induced cell 
death: influence of intracellular NAD consumption on the regulation 
of necrosis and apoptosis. Virus Res. 1999;65(2):161–174.
  33.  Di Piazza M, Mader C, Geletneky K, et al. Cytosolic activation of 
cathepsins mediates parvovirus H-1-induced killing of cisplatin and 
TRAIL-resistant glioma cells. J Virol. 2007;81(8):4186–4198.
  34.  Nuesch JP, Rommelaere J. A viral adaptor protein modulating casein 
kinase II activity induces cytopathic effects in permissive cells. Proc 
Natl Acad Sci U S A. 2007;104(30):12482–12487.
  35.  Horiuchi M, Yamaguchi Y, Gojobori T, et al. Differences in the evolu-
tionary pattern of feline panleukopenia virus and canine parvovirus. 
Virology. 1998;249(2):440–452.
  36.  Truyen U, Gruenberg A, Chang SF, Obermaier B, Veijalainen P,   
Parrish CR. Evolution of the feline-subgroup parvoviruses and the 
control of canine host range in vivo. J Virol. 1995;69(8):4702–4710.
  37.  Cotmore SF, Tattersall P. The autonomously replicating parvoviruses 
of vertebrates. Adv Virus Res. 1987;33:91–174.
  38.  Pollock RVH, Carmichael LE. The Canine Parvoviruses. In: Tijssen P, 
editor. CRC Handbook of Parvoviruses. Vol 2. Boca Raton: CRC Press, 
Inc; 1990:113–134.
  39.  Parker JS, Murphy WJ, Wang D, O’Brien SJ, Parrish CR. Canine and 
feline parvoviruses can use human or feline transferrin receptors to 
bind, enter, and infect cells. J Virol. 2001;75(8):3896–3902.
  40.  Bauder B, Suchy A, Gabler C, Weissenbock H. Apoptosis in feline 
panleukopenia and canine parvovirus enteritis. J Vet Med B Infect Dis 
Vet Public Health. 2000;47(10):775–784.
  41.  Parrish CR. Mapping specific functions in the capsid structure of canine 
parvovirus and feline panleukopenia virus using infectious plasmid 
clones. Virology. 1991;183(1):195–205.
  42.  Crissman HA, Steinkamp JA. Rapid, simultaneous measurement of 
DNA, protein, and cell volume in single cells from large mammalian 
cell populations. J Cell Biol. 1973;59(3):766–771.
  43.  Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST,   
van Oers MH. Annexin V for flow cytometric detection of phos-
phatidylserine expression on B cells undergoing apoptosis. Blood. 
1994;84(5):1415–1420.
  44.  Solovyan V , Salminen A. A rapid and efficient method for preparation 
of genomic DNA suitable for analysis of both high and low molecular 
weight DNA fragmentation during neuronal apoptosis. Brain Res Brain 
Res Protoc. 1999;4(3):335–340.
  45.  Bortner CD, Cidlowski JA. Caspase independent/dependent regulation 
of K(+), cell shrinkage, and mitochondrial membrane potential during 
lymphocyte apoptosis. J Biol Chem. 1999; 274(31):21953–21962.International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
428
Nykky et al
  46.  Parker JS, Parrish CR. Cellular uptake and infection by canine 
  parvovirus involves rapid dynamin-regulated clathrin-mediated endo-
cytosis, followed by slower intracellular trafficking. J Virol. 2000; 
74(4):1919–1930.
  47.  Suikkanen S, Saajarvi K, Hirsimaki J, et al. Role of recycling endosomes 
and lysosomes in dynein-dependent entry of canine parvovirus. J Virol. 
2002;76(9):4401–4411.
  48.  Suikkanen S, Aaltonen T, Nevalainen M, et al. Exploitation of 
  microtubule cytoskeleton and dynein during parvoviral traffic toward 
the nucleus. J Virol. 2003;77(19):10270–10279.
  49.  Suikkanen S, Antila M, Jaatinen A, Vihinen-Ranta M, Vuento M. 
Release of canine parvovirus from endocytic vesicles. Virology. 2003; 
316(2):267–280.
  50.  Vihinen-Ranta M, Kalela A, Makinen P, Kakkola L, Marjomaki V, 
Vuento M. Intracellular route of canine parvovirus entry. J Virol. 1998; 
72(1):802–806.
  51.  Martin SJ, Reutelingsperger CP, McGahon AJ, et al. Early redistribution 
of plasma membrane phosphatidylserine is a general feature of apoptosis 
regardless of the initiating stimulus: inhibition by overexpression of 
bcl-2 and abl. J Exp Med. 1995;182(5):1545–1556.
  52.  Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM. Initia-
tion of DNA fragmentation during apoptosis induces phosphorylation of 
H2AX histone at serine 139. J Biol Chem. 2000;275(13):9390–9395.
  53.  Talasz H, Helliger W, Sarg B, Debbage PL, Puschendorf B, Lindner H.   
Hyperphosphorylation of histone H2A.X and dephosphorylation of 
histone H1 subtypes in the course of apoptosis. Cell Death Differ. 
2002;9(1):27–39.
  54.  Overbeeke R, Steffens-Nakken H, Vermes I, Reutelingsperger C, Haanen C.   
Early features of apoptosis detected by four different flow cytometry 
assays. Apoptosis. 1998;3(2):115–121.
  55.  Kumar S. Caspase function in programmed cell death. Cell Death Differ. 
2007;14(1):32–43.
  56.  Chang HY, Yang X. Proteases for cell suicide: functions and regulation 
of caspases. Microbiol Mol Biol Rev. 2000;64(4):821–846.
  57.  Sol N, Le Junter J, Vassias I, et al. Possible interactions between the 
NS-1 protein and tumor necrosis factor alpha pathways in erythroid 
cell apoptosis induced by human parvovirus B19. J Virol. 1999; 
73(10):8762–8770.
  58.  Cotmore SF, Tattersall P. DNA replication in the autonomous parvovi-
ruses. Semin Virol. 1995;6(5):271–281.
  59.  Lu C, Zhu F, Cho YY, et al. Cell apoptosis: requirement of H2A.X in 
DNA ladder formation, but not for the activation of caspase-3. Mol 
Cell. 2006;23(1):121–132.
  60.  Bakkenist CJ, Kastan MB. DNA damage activates ATM through 
intermolecular autophosphorylation and dimer dissociation. Nature. 
2003;421(6922):499–506.
  61.  Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998; 
281(5381):1309–1312.
  62.  Dussmann H, Rehm M, Kogel D, Prehn JH. Outer mitochondrial mem-
brane permeabilization during apoptosis triggers caspase-independent 
mitochondrial and caspase-dependent plasma membrane potential depo-
larization: a single-cell analysis. J Cell Sci. 2003;116(Pt 3):525–536.
  63.  Chen SP, Yang HL, Her GM, et al. Betanodavirus induces phosphati-
dylserine exposure and loss of mitochondrial membrane potential in 
secondary necrotic cells, both of which are blocked by bongkrekic acid. 
Virology. 2006;347(2):379–391.
  64.  Matsuyama S, Llopis J, Deveraux QL, Tsien RY, Reed JC. Changes in 
intramitochondrial and cytosolic pH: early events that modulate caspase 
activation during apoptosis. Nat Cell Biol. 2000;2(6):318–325.
  65.  Tiefenthaler M, Amberger A, Bacher N, et al. Increased lactate produc-
tion follows loss of mitochondrial membrane potential during apoptosis 
of human leukaemia cells. Br J Haematol. 2001;114(3):574–580.
  66.  Chen SP, Wu JL, Su YC, Hong JR. Anti-bcl-2 family members, zfBcl-
x(L) and zfMcl-1a, prevent cytochrome c release from cells undergo-
ing betanodavirus-induced secondary necrotic cell death. Apoptosis. 
2007;12(6):1043–1060.
  67.  Hong JR, Lin TL, Hsu YL, Wu JL. Apoptosis precedes necrosis of fish 
cell line with infectious pancreatic necrosis virus infection. Virology. 
1998;250(1):76–84.
  68.  Goldspink DF, Burniston JG, Ellison GM, Clark WA, Tan LB. 
Catecholamine-induced apoptosis and necrosis in cardiac and skeletal 
myocytes of the rat in vivo: The same or separate death pathways?   
Exp Physiol. 2004;89(4):407–416.
  69.  Singh P. Tumor targeting using canine parvovirus nanoparticles. Curr 
Top Microbiol Immunol. 2009;327:123–141.
  70.  Li J, Werner E, Hergenhahn M, et al. Expression profiling of human 
hepatoma cells reveals global repression of genes involved in cell pro-
liferation, growth, and apoptosis upon infection with parvovirus H-1. 
J Virol. 2005;79(4):2274–2286.